AtriCure, Inc. (ATRC)
NASDAQ: ATRC · IEX Real-Time Price · USD
23.37
-0.08 (-0.34%)
Apr 18, 2024, 3:59 PM EDT - Market closed
AtriCure Market Cap
AtriCure has a market cap or net worth of $1.13 billion as of April 18, 2024. Its market cap has decreased by -41.80% in one year.
Market Cap
1.13B
Enterprise Value
1.05B
1-Year Change
-41.80%
Ranking
Category
Stock Price
$23.37
Market Cap Chart
Since August 5, 2005, AtriCure's market cap has increased from $167.60M to $1.13B, an increase of 575.11%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 1.12B | 1.51% |
| Apr 16, 2024 | 1.10B | 0.87% |
| Apr 15, 2024 | 1.09B | -4.94% |
| Apr 12, 2024 | 1.15B | -4.82% |
| Apr 11, 2024 | 1.20B | -2.27% |
| Apr 10, 2024 | 1.23B | -6.20% |
| Apr 9, 2024 | 1.31B | 4.03% |
| Apr 8, 2024 | 1.26B | 1.06% |
| Apr 5, 2024 | 1.25B | 0.43% |
| Apr 4, 2024 | 1.24B | -1.25% |
| Apr 3, 2024 | 1.26B | -2.69% |
| Apr 2, 2024 | 1.29B | -6.46% |
| Apr 1, 2024 | 1.38B | -4.37% |
| Mar 28, 2024 | 1.45B | 0.93% |
| Mar 27, 2024 | 1.43B | 3.61% |
| Mar 26, 2024 | 1.38B | 3.11% |
| Mar 25, 2024 | 1.34B | -0.91% |
| Mar 22, 2024 | 1.35B | -4.24% |
| Mar 21, 2024 | 1.41B | -2.43% |
| Mar 20, 2024 | 1.45B | -3.30% |
| Mar 19, 2024 | 1.50B | -1.35% |
| Mar 18, 2024 | 1.52B | -0.62% |
| Mar 15, 2024 | 1.53B | -1.17% |
| Mar 14, 2024 | 1.55B | -4.32% |
| Mar 13, 2024 | 1.62B | -2.75% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 1.16B |
| Prothena Corporation | 1.15B |
| Collegium Pharmaceutical | 1.13B |
| Vir Biotechnology | 1.13B |
| Mirum Pharmaceuticals | 1.12B |
| MannKind | 1.10B |
| Scholar Rock Holding | 1.09B |
| Centessa Pharmaceuticals | 1.09B |